Search

everythinglearnresearchcommunity

for

Search:↓

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Melanoblasts migrate to the skin using various pathways, and understanding this process could help with skin disease research.

Melanoma occurs more on the left side of the body, unlike other skin cancers.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

The conclusion is that a certain test might help find cancer spread in lymph nodes for melanoma patients, but more research is needed due to false positives.

Moles may stop growing due to cell cooperation, not just because of individual cell aging.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Hair turning darker can be a sign of skin cancer.

Melanocyte stem cells from non-affected skin in vitiligo patients can become functional melanocytes for potential therapy.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Keratin 15 cells from hair follicles help develop and maintain skin tumors in mice.

The research showed how melanocytes develop, move, and respond to UV light, and their stem cells' role in hair color and skin cancer risk.

Early subungual melanoma might be treated with less aggressive surgery because it invades the skin under the nail more slowly.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Trichoblastomas may mimic fetal skin development by having many Merkel cells, unlike adult skin.

A unique skin cell similar to hair bulb melanocytes was identified, with better preservation using permanganate fixation.

An automated method accurately assesses melanoma risk using 3D body images to analyze skin traits.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

The research shows that skin cancer likely originates from hair follicles and that certain cell populations expand to promote skin cancer growth.

Enhancing melanin's energy generation may help treat alopecia areata.

Lasers can help reduce skin side effects from cancer treatment.

Some patients on immune therapy for melanoma may develop scarring hair loss, but cancer treatment remains effective.

A new method can detect mutations in mice by observing changes in hair follicle cells.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Melanoma research shifted focus to immunotherapy drugs after 2010, increasing their study and citations.

The study found markers indicating that cells responsible for hair color are differentiating in specific areas of the hair follicle.

The technique can isolate cells to help treat skin pigmentation issues.

Mutant cells in hair follicles are influenced by their location and interactions with surrounding cells.